Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA PFIZER NATCO PHARMA/
PFIZER
 
P/E (TTM) x 13.3 38.2 34.9% View Chart
P/BV x 3.5 6.0 58.5% View Chart
Dividend Yield % 0.6 1.7 34.6%  

Financials

 NATCO PHARMA   PFIZER
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
PFIZER
Mar-23
NATCO PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs8474,662 18.2%   
Low Rs5023,407 14.7%   
Sales per share (Unadj.) Rs148.4530.0 28.0%  
Earnings per share (Unadj.) Rs39.2136.4 28.7%  
Cash flow per share (Unadj.) Rs48.2159.4 30.2%  
Dividends per share (Unadj.) Rs5.5070.00 7.9%  
Avg Dividend yield %0.81.7 47.0%  
Book value per share (Unadj.) Rs267.1701.0 38.1%  
Shares outstanding (eoy) m182.4745.75 398.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.57.6 59.7%   
Avg P/E ratio x17.229.6 58.1%  
P/CF ratio (eoy) x14.025.3 55.3%  
Price / Book Value ratio x2.55.8 43.9%  
Dividend payout %14.051.3 27.3%   
Avg Mkt Cap Rs m123,049184,576 66.7%   
No. of employees `000NANA-   
Total wages/salary Rs m4,8673,317 146.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,07124,248 111.6%  
Other income Rs m1,2851,011 127.2%   
Total revenues Rs m28,35625,258 112.3%   
Gross profit Rs m9,1178,420 108.3%  
Depreciation Rs m1,6381,055 155.2%   
Interest Rs m145135 107.6%   
Profit before tax Rs m8,6198,240 104.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4662,001 73.3%   
Profit after tax Rs m7,1536,239 114.6%  
Gross profit margin %33.734.7 97.0%  
Effective tax rate %17.024.3 70.0%   
Net profit margin %26.425.7 102.7%  
BALANCE SHEET DATA
Current assets Rs m30,00324,933 120.3%   
Current liabilities Rs m6,8316,574 103.9%   
Net working cap to sales %85.675.7 113.0%  
Current ratio x4.43.8 115.8%  
Inventory Days Days6393 67.9%  
Debtors Days Days1152 5,053.8%  
Net fixed assets Rs m26,57113,780 192.8%   
Share capital Rs m365458 79.8%   
"Free" reserves Rs m48,37331,616 153.0%   
Net worth Rs m48,73832,073 152.0%   
Long term debt Rs m00-   
Total assets Rs m56,57439,031 144.9%  
Interest coverage x60.462.1 97.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.6 77.0%   
Return on assets %12.916.3 79.0%  
Return on equity %14.719.5 75.4%  
Return on capital %18.026.1 68.9%  
Exports to sales %02.8 0.0%   
Imports to sales %10.20 29,558.2%   
Exports (fob) Rs mNA688 0.0%   
Imports (cif) Rs m2,7728 33,000.0%   
Fx inflow Rs m17,256688 2,508.9%   
Fx outflow Rs m2,7728 33,000.0%   
Net fx Rs m14,484679 2,131.9%   
CASH FLOW
From Operations Rs m8,4913,557 238.7%  
From Investments Rs m-4,771-361 1,323.4%  
From Financial Activity Rs m-3,630-3,458 105.0%  
Net Cashflow Rs m208-262 -79.5%  

Share Holding

Indian Promoters % 49.7 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 25.0 18.2 137.3%  
FIIs % 13.7 3.0 452.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 36.1 139.4%  
Shareholders   207,571 112,456 184.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs Pfizer Share Price Performance

Period Natco Pharma Pfizer S&P BSE HEALTHCARE
1-Day -2.11% -4.80% 1.18%
1-Month -3.19% -8.24% -0.75%
1-Year 72.80% 21.78% 61.82%
3-Year CAGR 4.96% -2.07% 18.16%
5-Year CAGR 10.96% 4.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.